60 Degrees Pharmaceuticals presents at H.C. Wainwright; no specific updates disclosed in filing

60 DEGREES PHARMACEUTICALS, INC.

CEO Geoff Dow scheduled to present to investors starting September 9, 2025.
Slide deck furnished to investors; filing text does not contain its substantive content.
No financial figures, guidance, or pipeline milestones provided in the 8-K.
Company is an emerging growth company listed on Nasdaq under SXTP and SXTPW.

item 7.01item 9.01

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.